Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct;25(5):673-685.
doi: 10.1007/s13365-019-00735-0. Epub 2019 Mar 13.

Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders

Affiliations
Review

Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders

Jacqueline Rosenthal et al. J Neurovirol. 2019 Oct.

Abstract

HIV-associated neurocognitive disorders (HAND) continue to affect a large proportion of persons living with HIV despite effective viral suppression with combined antiretroviral therapy (cART). Importantly, milder versions of HAND have become more prevalent. The pathogenesis of HAND in the era of cART appears to be multifactorial with contributions from central nervous system (CNS) damage that occur prior to starting cART, chronic immune activation, cART neurotoxicity, and various age-related comorbidities (i.e., cardiovascular and cerebrovascular disease, diabetes, hyperlipidemia). Individuals with HIV may experience premature aging, which could also contribute to cognitive impairment. Likewise, degenerative disorders aside from HAND increase with age and there is evidence of shared pathology between HAND and other neurodegenerative diseases, such as Alzheimer's disease, which can occur with or without co-existing HAND. Given the aforementioned complex interactions associated with HIV, cognitive impairment, and aging, it is important to consider an age-appropriate differential diagnosis for HAND as the HIV-positive population continues to grow older. These factors make the accuracy and reliability of the diagnosis of mild forms of HAND in an aging population of HIV-infected individuals challenging. The complexity of current diagnosis of mild HAND also highlights the need to develop reliable biomarkers. Ultimately, the identification of a set of specific biomarkers will be required to achieve early and accurate diagnosis, which will be necessary assuming specific treatments for HAND are developed.

Keywords: HAND; HIV; aging; biomarkers; cognitive impairment.

PubMed Disclaimer

Figures

Figure 1-
Figure 1-
A. Axial T2 FLAIR image of an Alzheimer’s disease patient demonstrating pronounced cortical atrophy; B. Axial T2 FLAIR image of an HAND patient with less pronounced cortical atrophy though mild hydrocephalus ex vacuo can still be appreciated.

Similar articles

Cited by

References

    1. Heaton RK, et al., HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 2010. 75(23): p. 2087–96. - PMC - PubMed
    1. Sacktor N, et al., Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology, 2016. 86(4): p. 334–40. - PMC - PubMed
    1. Petersen RC, et al., Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology, 2018. 90(3): p. 126–135. - PMC - PubMed
    1. Antinori A, et al., Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 2007. 69(18): p. 1789–99. - PMC - PubMed
    1. Rumbaugh JA and Tyor W, HIV-associated neurocognitive disorders: Five new things. Neurol Clin Pract, 2015. 5(3): p. 224–231. - PMC - PubMed

MeSH terms